用萘呋胺酯或双嘧达莫延长前列环素的生成。 - Suppr

Prolonging prostacyclin production by nafazatrom or dipyridamole.

作者信息

Deckmyn H, Gresele P, Arnout J, Todisco A, Vermylen J

出版信息

Lancet. 1984 Aug 18;2(8399):410-1. doi: 10.1016/s0140-6736(84)90582-8.

DOI:10.1016/s0140-6736(84)90582-8

PMID:6147492

Abstract

摘要

相似文献

Prolonging prostacyclin production by nafazatrom or dipyridamole.

Lancet. 1984 Aug 18;2(8399):410-1. doi: 10.1016/s0140-6736(84)90582-8.

Drug effects on output of prostacyclin from isolated lungs.

Biochem Pharmacol. 1987 Oct 15;36(20):3540-3. doi: 10.1016/0006-2952(87)90341-8.

Mechanism of the stimulation of prostaglandin H synthase and prostacyclin synthase by the antithrombotic and antimetastatic agent, nafazatrom.

Mol Pharmacol. 1984 Sep;26(2):328-35.

Investigations on the role of arachidonic acid metabolism pathways in the antithrombotic activity of nafazatrom and molsidomine.

Thromb Res. 1988 Jun 1;50(5):617-25. doi: 10.1016/0049-3848(88)90320-9.

Enhanced prostacyclin production by dipyridamole in man.

Eur J Clin Pharmacol. 1981;21(1):9-15. doi: 10.1007/BF00609581.

Nafazatrom (BAY g 6575), a potent stimulator of prostacyclin release from cardiac and renal vessel wall.

Arch Int Pharmacodyn Ther. 1984 Oct;271(2):220-8.

[Dose-dependent increase in prostacyclin synthesis from various vascular tissues by dipyridamole].

Wien Klin Wochenschr. 1982 Dec 10;94(23):630-2.

Dipyridamole: a potent stimulator of prostacyclin (PGI2) biosynthesis.

Br J Pharmacol. 1980 Jan;68(1):71-3. doi: 10.1111/j.1476-5381.1980.tb10700.x.

Antiaggregatory efficacy and its time-course after application of acetylsalicylic acid, prostacyclin and nafazatrom in vivo.

Arch Int Pharmacodyn Ther. 1984 Nov;272(1):150-8.

Nafazatrom (Bay g-6575), an antithrombotic and antimetastatic agent, inhibits 15-hydroxyprostaglandin dehydrogenase.

J Pharmacol Exp Ther. 1982 Dec;223(3):757-60.

引用本文的文献

Antiplatelet Therapy for Atherothrombotic Disease in 2022-From Population to Patient-Centered Approaches.

Front Cardiovasc Med. 2022 Jan 28;9:805525. doi: 10.3389/fcvm.2022.805525. eCollection 2022.

Anti-platelet therapy: phosphodiesterase inhibitors.

Br J Clin Pharmacol. 2011 Oct;72(4):634-46. doi: 10.1111/j.1365-2125.2011.04034.x.

Current issues in thrombosis prevention with antiplatelet drugs.

Drugs. 1986 Jun;31(6):517-49. doi: 10.2165/00003495-198631060-00004.

[Prevalence of plasma factor deficiency in the Vienna population. Results of a screening study of 1,300 adults].

Klin Wochenschr. 1988 Sep 1;66(17):779-83. doi: 10.1007/BF01726578.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Prolonging prostacyclin production by nafazatrom or dipyridamole.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献